The authors have found that high doses of vitamin C selectively killed colon cancer cells harboring mutated BRAF or KRAS through hyperaccumulation of its oxidized form, DHA, via GLUT-1. The gene discussed is SLC2A1; the disease is malignant colon neoplasm.